AtterwillC.K., & WingM.G. (2000). In vitro pre-clinical lead optimisation technologies (PLOTs) in pharmaceutical development. ATLA28, 857–867.
2.
BrunerL.H., CarrG.J., & CurrenR.D. (2000). Is it good enough? Objective assessment of toxicity test method performance in validation studies. In Progress in the Reduction, Refinement and Replacement of Animal Experimentation (ed. BallsM., van ZellerA-M., & HalderM.E.), pp. 375–384. Amsterdam, The Netherlands: Elsevier.
3.
FryJ.R. (2000). Cytotoxicity and mechanistic studies in high throughput toxicity screening. In Approaches to High Throughput Toxicity Screening (ed. AtterwillC.K., GoldfarbP., & PurcellW.), pp. 31–42. London, UK: Taylor & Francis.
4.
BallsM. (2000). The future of high throughput screening and pharmacotoxicology. In Approaches to High Throughput Toxicity Screening (ed. AtterwillC.K., GoldfarbP., & PurcellW.), pp. 171–178. London, UK: Taylor & Francis.